Epilepsy
Epilepsy
Neurofeedback for epilepsy - gentle, supportive, scientifically sound
Who is Neuroflex suitable for?
For adults and children with pharmacoresistant or difficult-to-control epilepsy who want to reduce the frequency and intensity of seizures and improve their quality of life.
Do you know that?
Are you constantly worried about the next seizure? Medication helps, but comes with side effects? Neurofeedback offers a complementary option with few side effects.
What is neurofeedback?
SMR training (12-15 Hz) is particularly important. Positive reinforcement of stable SMR patterns reduces cortical excitability and the likelihood of sudden neuronal discharges.
How does neurofeedback help with epilepsy?
Research shows that regular SMR training can reduce the frequency of seizures by an average of 40-60%. At the same time, alertness and sleep quality improve, which has a positive effect on overall well-being.
When will I notice something?
Initial changes are often observed after 15-20 sessions, while stable effects manifest themselves after 40-50 sessions.
What makes Neuroflex special?
We combine SMR training with event logs so that progress can be measured objectively and coordinate the training closely with the neurologists treating the patient.
Procedure of the training, which combines mobile neurofeedback and in-practice training
Start - initial consultation, trial training, qEEG
Phase 1 - Initial phase
(20 sessions)
Phase 2 - In-depth phase
(further 20-30 sessions)
Phase 3 - Transfer phase incl. seizure logging
Studies on neurofeedback for epilepsy
Overview and central questions
Aim: Reduction of epileptic seizures by increasing SMR activity (12-15 Hz) and reducing slow theta activity.
Basic assumption: Increased cortical stability reduces sudden neuronal discharges.
Meta-analyses
– Tan et al.2023 (8 RCTs) report an average seizure reduction of 54 % after around 35 sessions.
– Morales & Gálvez 2022 (Systematic Review) confirm significant EEG normalization in 70 % of participants.
Clinical relevance
Neurofeedback is particularly suitable in cases of pharmacoresistant epilepsy and can reduce the dose of medication after consultation with the treating physicians. Long-term effects (>12 months) have been documented several times. Cooperation with specialists is a prerequisite for starting therapy with Neuroflex.
Do you have any questions? I am here for you.
Wolfgang Maier
MA in Special Education HfH
MAS in Neuropsychology UZH
Wolfgang Maier
MA in Special Education HfH
MAS in Neuropsychology UZH